The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Provera 2.5 mg tablets



Pfizer Healthcare IrelandPA0822/134/001

Main Information

Trade NameProvera 2.5 mg tablets
Active SubstancesMedroxyprogesterone acetate
Dosage FormTablet
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/134/001

Group Information

ATC CodeG03DA Pregnen (4) derivatives
G03DA02 medroxyprogesterone

Status

License statusAuthorised
Licence Issued27/10/1993
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back